// company-profile

Barinthus Biotherapeutics plc. Insider Trading

BRNS

Every SEC Form 4 insider trading filing for Barinthus Biotherapeutics plc. (BRNS) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.X0Filings29Insiders11
// api This Barinthus Biotherapeutics plc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=BRNS" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for BRNS in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Barinthus Biotherapeutics plc. as of 2026-06-30

— stable
Total reported AUM
$6.0M
QoQ change
Reporting period
2026-06-30
#1
M&G PLC
CIK 1802539
$5.2M
5.2M shares
#2
GLR Partners, LLC
CIK 2134831
$820,629
1.2M shares
#3
HighTower Advisors, LLC
CIK 1462245
$24,717
37K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 10, 2025DAWES KAREN ABRNS
Award
20,174$0.00$0K
Jun 10, 2025Hammacher AlexBRNS
Award
20,174$0.00$0K
Jun 10, 2025Wright RobinBRNS
Award
20,174$0.00$0K
Jun 10, 2025Morgon Pierre A.BRNS
Award
20,174$0.00$0K
Jun 10, 2025Phillips Anne M.BRNS
Award
20,174$0.00$0K

24 more transactions hidden

Free account · No credit card required

Building something? Get API access →